Key Takeaways Hologic raised its 2025 guidance midpoints after a strong Q3 and easing tariff headwinds.Hologic's Breast Health sales topped forecasts, with new leadership and innovation driving momentum.Hologic's GYN Surgical surged internationally, up 24.8% in Q3, with strong growth expected in Q4.On its July 2025 earnings call, Hologic (HOLX) said that it is well on track with the financial improvement plan laid out earlier this year. The company raised the midpoints of its fiscal 2025 guidance ranges, wi ...